Synbio Tech (1295.TWO) Stock Price
Synbio Tech Price
Revenue has compounded at 7.1% per year over the past 5 years to 1.04 B TWD. Earnings per share have grown at 6.0% per year over the last 5 years. Synbio Tech's net margin stands at 16.9%, down from 18.7% several years earlier. Synbio Tech currently offers a dividend yield of about 6.99%. The payout ratio is around 69% of earnings.
Synbio Tech stock price
Synbio Tech business model & stock analysis
Frequently asked questions about Synbio Tech
9 analysts currently rate the Synbio Tech stock: 8 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Synbio Tech to generate revenue of 1.26 B TWD and earnings per share of 6.26 TWD.
Converted at the current exchange rate, the Synbio Tech share trades at 1.40 EUR (50.10 TWD).
The expected revenue of Synbio Tech is 1.26 B TWD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Synbio Tech is 216.17 M TWD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Synbio Tech is currently 8.00. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Synbio Tech stock.
The price-to-sales ratio (P/S) of Synbio Tech is currently 1.38. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Synbio Tech stock.
The Eulerpool Quality Score for Synbio Tech is 4/10.
The ISIN of Synbio Tech is TW0001295004. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Synbio Tech is 1295.TWO. The ticker symbol is used to trade Synbio Tech shares on the stock exchange.
Synbio Tech stock
Synbio Tech Peer Group
All fundamentals and in-depth analysis of Synbio Tech
Our stock analysis for Synbio Tech stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Synbio Tech. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.